Consistent with the fact that TRPV4 is a Ca2+-permeable non-selective channel, the activation of TRPV4 by GSK1016790A increased Ca2+ influx in NPC cells, which was suppressed by pharmacological inhibition or gene silencing of TRPV4. Here, TRPV4 is linked to nasopharyngeal carcinoma.